46‐1: 1218 ppi Quest 3 Display by Hybrid Backplane with Highly Reliable IGZO TFTs
SID Symposium Digest of Technical Papers · 2024-06 · 55 (1) · 615-618
DOI: 10.1002/sdtp.17599 ↗Kurz gefasst
Fachartikel in der Zeitschrift SID Symposium Digest of Technical Papers, online erschienen am 30.07.2024. Verfasst von Atsushi Hachiya und 15 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 7 Literaturangaben.
Abstract (Originalsprache)
A 2.48‐inch with 1218 ppi, LCD panel for Quest 3 using hybrid backplane technology with CMOS‐LTPS and IGZO TFTs were manufactured. The hybrid TFT structure achieves high resolution and high transmittance simultaneously, and also ensures high reliability. The fabricated LCD panel has proven to be highly reliable, enduring 1000 hours in aging tests, and has been successfully mass‐produced.
Zitieren
APA
Hachiya, A., Aman, M., Chiu, H., Shinohara, T., Lin, W. Y., Nemati, H., Takeuchi, Y., Ito, K., Saitoh, Y., Furukawa, H., Takeda, Y., Matsukizono, H., Rao, L., Choi, J., Itoh, Y., & Zhuang, J. (2024). 46‐1: 1218 ppi Quest 3 Display by Hybrid Backplane with Highly Reliable IGZO TFTs. SID Symposium Digest of Technical Papers, 55(1), 615-618. https://doi.org/10.1002/sdtp.17599
Vancouver
Hachiya A, Aman M, Chiu H, Shinohara T, Lin WY, Nemati H, et al. 46‐1: 1218 ppi Quest 3 Display by Hybrid Backplane with Highly Reliable IGZO TFTs. SID Symposium Digest of Technical Papers. 2024;55(1):615-618. doi:10.1002/sdtp.17599
BibTeX
@article{Hachiya2024,
author = {Hachiya, Atsushi and Aman, Mehadi and Chiu, Hsin-Ying and Shinohara, Takushi and Lin, Wan Yu and Nemati, Hossein and Takeuchi, Yohei and Ito, Kazuatsu and Saitoh, Yuich and Furukawa, Hiroaki and Takeda, Yujiro and Matsukizono, Hiroshi and Rao, Linghui and Choi, Jacob and Itoh, Yasuhisa and Zhuang, Jim},
title = {46‐1: 1218 ppi Quest 3 Display by Hybrid Backplane with Highly Reliable IGZO TFTs},
journal = {SID Symposium Digest of Technical Papers},
year = {2024},
volume = {55},
number = {1},
pages = {615--618},
doi = {10.1002/sdtp.17599}
}
EUVIMED